Corporate
Agios Wins Historic FDA Approval: AQVESME Becomes First Oral Therapy for Broad Thalassemia Population
Dec 24, 2025
You're signed outSign in or to get full access.
AGIOS PHARMACEUTICALS (AGIO) Earnings Call Transcripts
Browse quarterly earnings call transcripts for AGIOS PHARMACEUTICALS.